Mersana Therapeutics Inc (MRSN)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -22.93 | -32.83 | -61.426 | -30.324 | -46.225 | -70.931 | -75.571 | -61.267 |
Return on Equity (%) | 27.871 | -538.532 | -163.112 | -64.762 | -57.47 | -97.225 | -191.033 | -266.236 |
Return on Invested Capital (%) | 27.889 | -2563.378 | -197.658 | -68.146 | -56.404 | -89.927 | -156.15 | -203.99 |
Operating Margin (%) | -54.428 | -220.616 | -606.541 | -66.41 | -10590.097 | -392541.86 | -755.743 | -454.747 |
Net Profit Margin (%) | -54.428 | -220.616 | -606.541 | -66.966 | -10633.454 | -395488.372 | -768.263 | -465.798 |
Book Value Per Share | -9.548 | 3.075 | 0.379 | 1.726 | 3.313 | 1.652 | 0.884 | 0.306 |
Earnings Per Share | -2.352 | -1.7 | -2.766 | -0.621 | -1.279 | -2.307 | -1.961 | -1.424 |
Cash Per Share | 17.218 | 1.168 | 2.567 | 1.374 | 3.706 | 2.414 | 1.237 | 1.448 |
Working Capital Per Share | 12.667 | 3.763 | 0.21 | 1.702 | 3.32 | 1.918 | 2.186 | 1.247 |
Operating Profit Per Share | 4.321 | 0.771 | 0.456 | 0.928 | 0.012 | 0.001 | 0.255 | 0.306 |
EBIT Per Share | -2.352 | -1.7 | -2.766 | -0.621 | -1.279 | -2.307 | -1.961 | -1.424 |
EBITDA Per Share | -2.352 | -1.7 | -2.766 | -0.621 | -1.279 | -2.307 | -1.961 | -1.424 |
Free Cash Flow Per Share | -2.278 | -1.691 | -2.761 | -0.636 | -1.287 | -2.31 | -1.948 | -1.418 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.83M | 22.77M | 23.23M | 45.39M | 68.84M | 73.71M | 104.16M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 98.58M | 104.16M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -707.255 | N/A | N/A | N/A | -197.988 | N/A |
Net Profit Margin (%) | N/A | N/A | -719.854 | N/A | N/A | N/A | -208.826 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 270.54M |
Price to Earnings Ratio | -1.64 |
Price to Sales Ratio | 7.64 |
Price to Cash Ratio | 1.61 |
Price to Book Ratio | 7.63 |
Dividend Yield | - |
Shares Outstanding | 123.53M |
Average Volume (1 week) | 1.38M |
Average Volume (1 Month) | 1.51M |
52 Week Change | 49.02% |
52 Week High | 6.2801 |
52 Week Low | 1.22 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.